Director of Education, Governance and Operations at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Experience leading cross-functional teams with global impact in events, meetings, education, governance, or operations
Expertise in compliance, ethics, and risk management, particularly for E&M processes
Strong strategic planning and execution skills, including development of operations strategy for E&M
Ability to provide counsel, influence, and partnership at senior levels, including to global E&M leadership
Proficiency in data-driven decision-making and fact-based insights
Knowledge of vendor management, outsourcing, training, and platform oversight for HCP meetings
Capability to drive process simplification, policy shaping, and transformational change in a complex matrix environment
Direct management experience, including leading teams like the Contracting Hub (ZS and BMS contracted individuals) focused on contracts, invoicing, and payments
Understanding of regulatory requirements, reputational risks, and financial robustness in pharmaceutical operations

Responsibilities

Lead and develop strategy and execution for education, governance, and operations in Events & Meetings (E&M) globally
Drive enhancements to operations, including tech stack for HCP meetings, vendor partnerships, commercialization model changes, education, governance, launch effectiveness, operating model changes, technical platform oversight, and registration platforms
Act as global process owner for E&M processes and governance framework, ensuring alignment and policy harmonization
Drive transformational change and lead complex projects in a matrix environment
Directly manage the Contracting Hub teams (ZS individuals and BMS contracted individuals) accountable for contract production, invoicing, and payments
Proactively manage E&M compliance risks, working with Risk, Operations, and Intelligence teams (ROI)
Streamline processes, own vendor performance, shape policy, and focus on HCP experience
Interact with and advise senior-level BMS management on E&M strategy and operations
Ensure efficient, expedited, and compliant operations for internal and external E&M activities

Skills

Leadership

Team Management

Compliance

Ethics

Governance

Operations

Events Management

Strategy Development

Risk Management

Cross-functional Collaboration

Vendor Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free